Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

In This Issue

J Immunol October 15, 2012, 189 (8) 3785-3786; DOI: https://doi.org/10.4049/jimmunol.1290061
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

MASP-1, the Lectin Leader

The complement system includes the classical, alternative, and lectin pathways, each of which is triggered by different molecular mechanisms. Mannan-binding lectins (MBLs) or ficolins form complexes with different MBL-associated serine proteases (MASPs) and bind to carbohydrate or glycoprotein ligands on microbes to activate the lectin pathway. Degn et al. (p. 3957) now better define roles for MASP-1 in the lectin pathway using both clinical samples and biochemical analysis. A patient identified with a nonsense mutation in MASP1 did not have detectable serum levels of any of the three MASP proteins (MASP-1, MASP-3, and MAp44) encoded by this gene. The alternative pathway functioned normally in the sera of this patient, despite previous data indicating a role for MASP-1 and MASP-3 in this pathway. In contrast, the lectin pathway was defective in this MASP1−/− patient. Further analysis using in vitro reconstitution assays demonstrated that MASP-1 was required for activation of the lectin pathway. At physiological levels, MASP-1 increased activation of the lectin pathway by activating MASP-2, and this transactivation was likely caused by complexes formed by MASP-1, MASP-2, and MBL. Together these results discern a role for MASP-1 in activation of the lectin pathway in humans.

Figure1

Airway Adjuster

The molecular mechanisms that contribute to airway hyperresponsiveness (AHR) and asthma are not well understood, but recent studies have linked several members of the a disintegrin and metalloproteinase (ADAM) enzyme family to AHR. ADAM with thrombospondin motifs 12 (ADAMTS12) has been characterized recently as an asthma susceptibility gene in humans, and Paulissen et al. (p. 4135) developed Adamts12−/− mice to better understand its role in allergen-induced AHR. Exposure of wild-type mice to either OVA or house dust mite (HDM) allergens induced expression of Adamts-12 mRNA in the lungs. Adamts12−/− mice developed more severe AHR than wild-type mice following OVA or HDM challenge, which was associated with greater eosinophil infiltration in airway tissues and higher levels of allergen-specific IgG1 and IgE. In addition, mast cell recruitment and levels of ST2 and its ligand, IL-33, were higher in Adamts12−/− mice in response to challenge with these allergens. Overall, these observations indicate that Adamts12 may modulate inflammation that contributes to AHR and asthma and thus protect airways against excessive inflammation.

Half Life—The Peptide Predictor

CD4+ T cells are activated during viral infection in part through recognition of viral peptides presented by MHC class II (MHC II) molecules on APCs. Following proteolytic cleavage of viral proteins, peptides are loaded onto MHC II molecules through a peptide exchange process involving the nonclassical MHC II molecule HLA-DM (DM). Yin et al. (p. 3983) now assess the role of HLA-DM in peptide selection during vaccinia virus infection of human CD4+ T cells. They measured multiple binding properties, including the IC50, intrinsic disassociation half-life, DM-mediated disassociation half-life, and DM-susceptibility, of HLA-DR1–restricted epitopes derived from the A10L viral core protein relative to nonepitopes. All of these properties differed between epitopes and nonepitopes, although the DM-mediated half-life differed the most significantly. The DM-mediated half-life of HLA-DR1–A10L peptide complexes was the most robust predictor of CD4+ T cell epitopes, such that complexes with longer DM-mediated half-lives were associated with more immunodominant epitopes. This relationship was confirmed with peptides from other vaccinia virus proteins. Together, these results indicate that the DM-mediated dissociation half-life is an independent indicator that predicts peptide immunogenicity.

Autotaxin Aids Migration

The migration of naive T cells from the blood to secondary lymphoid organs (SLOs) can occur through high endothelial venules (HEVs) following a series of events that include rolling and arrest of T cells on the endothelial surface, intraluminal crawling, and transendothelial migration (TEM). Zhang et al. (p. 3914) now describe mechanisms by which the ectoenzyme autotaxin (ATX) contributes to these processes. Previous studies have shown that ATX is secreted by HEV endothelial cells (ECs) and can bind to T cells that have been activated by chemokines. In addition, ATX catalyzes a reaction that converts lysophosphatidyl choline (LPC) to lysophosphatidic acid (LPA), a bioactive lipid that has been observed to impact T cell migration. In this study, mice treated with the ATX inhibitor HA130 showed reduced T cell migration across HEVs in lymph nodes. Ex vivo studies showed that LPA alone or ATX combined with LPC could induce polarization and motility of naive T cells. LPA or ATX/LPC treatment could also promote TEM of T cells immobilized on ECs by integrin interactions under physiologic shear flow conditions. ATX binding was detected on the surface of T cells, particularly on the leading edge of polarized cells, and binding was enhanced by the presence of Mn2+, suggesting an interaction mediated by integrins. The authors propose a model in which localized ATX binding stimulates LPA production and thus promotes TEM. Thus, the ability of ATX to catalyze LPA formation plays a pivotal role in TEM of activated T cells.

Figure2

Switch Sequence Preference

B cell activation includes the generation of Ab diversity via somatic hypermutation (SHM) and class switch recombination (CSR) of Ig genes by activation-induced cytidine deaminase (AID). The Ig H chain locus undergoes CSR and SHM at switch (S) regions that are characterized by repetitive sequences, but the contribution of the sequences within S regions is not well understood. To assess the contribution of S region sequence to AID targeting independent of Igh cis regulatory elements, Chen et al. (p. 3970) used a knock-in mouse model in which a core Sγ1 region was inserted into the first intron of Bcl6. Bcl6 is involved in germinal center (GC) formation and is a non-Igh target of AID. The authors determined that the first intron of Bcl6 is an inefficient site of AID-mediated SHM. In GC B cells of Bcl6Sγ1/+ heterozygous mice, the Bcl6Sγ1 allele had a greater frequency of SHM than the wild-type Bcl6 allele. Relative to wild-type mice, the Sγ1 region in Bcl6Sγ1/ Sγ1 mice showed greater recruitment of AID and RNA polymerase II molecules. These results suggest that nucleotide sequences of S regions contribute to AID targeting, thus indicating another mechanism by which CSR and SHM are mediated.

Figure3

Dicing in the Thymus

Immature thymocytes develop into mature TCR-expressing T cells in the thymus through a series of steps guided by cells that form the thymic stroma, including thymic epithelial cells (TECs). MicroRNAs (miRNAs) are small noncoding RNAs recognized for their ability to modulate mRNA stability and translation and influence manifold biological mechanisms. Zuklys et al. (p. 3894) have assessed the effect miRNAs have on TEC function and T cell differentiation using a mouse strain with a TEC-targeted deficiency in Dicer (Foxn1-Cre::Dicerfl/fl), an enzyme required for miRNA generation. Thymic cellularity, as well as development of double positive (DP) thymocytes and single positive mature T cells, was significantly reduced in Foxn1-Cre::Dicerfl/fl mice relative to controls. In particular, Dicer deficiency in cortical TECs dramatically compromised T cell lineage commitment of early thymic progenitors, and was also associated with less effective maturation and positive selection of DP thymocytes. Gene expression profiling suggested that multiple processes were affected by Dicer deficiency in TECs, including the expression of genes involved in transcription, differentiation, and cell signaling. These findings suggest that T cell differentiation and selection, as well as development of central tolerance, are dependent on miRNA-mediated regulation of gene expression in TECs.

  • Copyright © 2012 by The American Association of Immunologists, Inc.
PreviousNext
Back to top

In this issue

The Journal of Immunology: 189 (8)
The Journal of Immunology
Vol. 189, Issue 8
15 Oct 2012
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Advertising (PDF)
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Immunology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
In This Issue
(Your Name) has forwarded a page to you from The Journal of Immunology
(Your Name) thought you would like to see this page from the The Journal of Immunology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
In This Issue
The Journal of Immunology October 15, 2012, 189 (8) 3785-3786; DOI: 10.4049/jimmunol.1290061

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
In This Issue
The Journal of Immunology October 15, 2012, 189 (8) 3785-3786; DOI: 10.4049/jimmunol.1290061
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • MASP-1, the Lectin Leader
    • Airway Adjuster
    • Half Life—The Peptide Predictor
    • Autotaxin Aids Migration
    • Switch Sequence Preference
    • Dicing in the Thymus
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Top Reads
  • In This Issue
  • In This Issue
Show more IN THIS ISSUE

Similar Articles

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • Public Access
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2021 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606